Kat Mayer-Barber,PhD
banner
mayerbarber.bsky.social
Kat Mayer-Barber,PhD
@mayerbarber.bsky.social
Cellular mucosal immunologist- lung- 🫁 innate immunity and inflammtion @IRP/NIAID/NIH - views my own
https://www.niaid.nih.gov/research/katrin-d-mayer-barber-dr-rer-nat-phd
🙌🏼🙌🏼 @heran.bsky.social
April 26, 2025 at 12:20 AM
We then administered TNF or IL-1 🫁 themselves, one week prior to #SARSCoV2 infection and both can confer this anti-viral state! Head explode TNF or IL-1 protection was Ifnar1-independent! 🤯6/9
December 6, 2024 at 10:38 PM
How do we know what inflammatory pathways can limit viral replication early in the lungs? We checked for ourselves and screened many KO mice in our favorite pathways…Turns out that besides IFNs, and their needed #PRRs TNF signaling is required, but IL-1 itself is not! 5/9
December 6, 2024 at 10:38 PM
All the preconditioning stimuli and pathogens we tested provided sustained IFN-activation of lung epithelial subsets (targets for viral replication) possibly contributing to enhanced control of #SARSCoV2 upon exposure. Interestingly, TLR conditioning required both IFNAR1 and IL1R1 (🤩) 4/9
December 6, 2024 at 10:38 PM
Recently resolved pulmonary bacterial or viral infection, underlying allergic asthma-like disease or even one-time admins of TLR ligands to the lung all potently limited #SARSCoV2 replication in the 🫁 3/9
December 6, 2024 at 10:38 PM
Best #Nikolaus 🎅! Our paper on how the 🫁 microenvironment can shape #innate immunity against #viruses is out @sciimmunology.bsky.social This was a herculean effort brilliantly led by @pauljbaker.bsky.social who singlehandedly established the model in the lab during the pandemic. 🧪 #Immunosky 1/9
December 6, 2024 at 10:38 PM
Post a pic for some zen
November 17, 2024 at 1:24 AM
@gpollara.bsky.social gave a brilliant seminar on the role of #IL-6 in tuberculosis today at the VALIDATE seminar series!
Turns out this may all be context dependent, and fits beautifully with what we proposed in our „Tipping-point“ model of TB disease and innate cytokines
November 6, 2024 at 3:58 PM
Finally we decided to try if TNF or IL-1 🫁administration alone, one week prior to #SARSCOV2 infection can also create this heightened anti-viral state. Well, yes, they totally can, and so far it seems IFN-independent! 7/10
April 21, 2024 at 12:28 AM
How do we know what inflammatory pathways can limit viral replication early in the lungs? We checked for ourselves and screened many KO mice in our favorite pathways…Turns out that besides IFNs, and their needed #PRRs TNF signaling is required, but IL-1 itself is not! 6/10
April 21, 2024 at 12:27 AM
The diverse preconditioning stimuli and pathogens sustained IFN-activation of different epithelial subsets (targets for viral replication) likely contributing to enhanced innate control of #SARSCOV2. Interestingly, TLR conditioning required both IFNAR1 and IL1R1 (🥰) 5/10
April 21, 2024 at 12:27 AM
One week after pulmonary TLR administration, the #TRM macrophages were still metabolically altered and activated, and in the case of #IM substantially expanded; we think IM may not be directly involved in protection (check out preprint), but #AMs are still contenders…4/10
April 21, 2024 at 12:26 AM
Recently resolved pulmonary bacterial or viral infection, underlying allergic asthma-like disease or even one-time admins of TLR ligands to the lung all potently limited #SARSCOV2 replication in the 3/10
April 21, 2024 at 12:25 AM